Sarah Moore

Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA

Nathan Clumeck, F. D. Goebel, Willy Rozenbaum et al. · AIDS · 2001 · 145 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Absence of zidovudine resistance in antiretroviral-naive patients following zidovudine/lamivudine/protease inhibitor combination therapy: virological evaluation of the AVANTI 2 and AVANTI 3 studies

Michael Maguire, Martin Gartland, Sarah Moore et al. · AIDS · 2000 · 70 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

In-Hospital Management of Diabetes

Janine Malcolm, Ilana Halperin, David B. Miller et al. · Canadian Journal of Diabetes · 2018 · 51 citations · Full text

Medicine, Health Services Administration, Internal Medicine +12

Mannan binding lectin concentration and risk of miscarriage

David C. Kilpatrick, Lora Starrs, Sarah Moore et al. · Human Reproduction · 1999 · 45 citations

Life Sciences, Genetics, Gynecology +11

Avanti 3: A Randomized, Double-Blind Trial to Compare the Efficacy and Safety of Lamivudine plus Zidovudine versus Lamivudine plus Zidovudine plus Nelfinavir in HIV-1-Infected Antiretroviral-Naive Patients

Martin Gartland, DA Cooper, Josep M. Gatell et al. · Antiviral Therapy · 2001 · 43 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17